TRIM33 and cancer: In addition, if skin manifestations are severe and/or complicated by dysphagia (in the absence of an interstitial lung abnormality (ILA)), and are not responding to corticosteroids, TIF-1γ antibody levels should be checked and cancer screening should be performed to rule out any potential malignancy involvement [22,23].